-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Rocket Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
- Rocket Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $11.2M, a 9.04% increase year-over-year.
- Rocket Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $42.8M, a 9.17% increase year-over-year.
- Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $39.4M, a 27.1% increase from 2022.
- Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31M, a 6.06% increase from 2021.
- Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.2M, a 57.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)